Doctors in Uganda treating type 2 diabetes patients with metformin—the main sugar-lowering pill—worry about vitamin B12 shortages that cause nerve damage, tiredness, and mood changes. This problem shows up through low blood B12 levels under 150 pg per ml, but real numbers in African clinics stay unknown. 
A team at Hoima Regional Referral Hospital checked 257 adults on metformin from February to April 2024. They used questionnaires, patient charts, and lab tests with a special light-up machine for B12. Logistic math found what raises risk. Neuropathy and brain symptoms got close looks too. The results were published in the Diabetes, Metabolic Syndrome, and Obesity. 
One in Ten Hit by B12 Shortage
Out of 257 patients, 10.1% had true B12 deficiency. This rate means doctors see it often enough to act.
Long High Doses Spark the Problem
Three big risks stood out after full checks. Metformin use over 10 years raised odds almost four times with adjusted odds ratio 3.94 and confidence from 1.34 to 11.56. Daily doses at 2000 mg bumped risk over four times at 4.32 from 1.47 to 12.67. Poor sugar control through high HbA1c added 2.63 times risk from 1.08 to 6.41.
Nerve Pain and Mood Hit Hardest
B12-low patients faced peripheral neuropathy at 76.9% versus 46.8%—a strong link at P=0.005. Neuropsychiatric issues like confusion or depression struck 50% against 28.6% at P=0.042.
Simple Screening Saves Nerves
Endocrinologists in Uganda gain clear triggers to test B12 yearly in long-term high-dose users. Shots or pills fix shortages fast before permanent nerve loss.
Routine Checks Fit Clinic Flow
Add B12 blood draws to yearly diabetes visits for at-risk folks. Early catches cut pain and mood woes, boosting care quality without big costs.